G.J. G.
- Country
- The Netherlands
- Department
- CHDR
Research Overview
- Assessment of Pharmacodynamic Effects of an Authorized Compound and a Novel Agent on Nerve Excitability in Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Study
- A Randomized, Double-Blind, Placebo-Controlled Study on Analgesic and CNS Effects of Morphine and Fluvoxamine in Chronic Pain in Healthy Subjects
- A randomized, double-blind, placebo-controlled 2-way crossover study to assess the analgesic effects of THC in patients with chronic neuropathic pain and to phenotype the responders to THC treatment.
Data & Insights
Has run more than one trial at 1 of 2 partner sites.
Specializations
Pain Management
This investigator specializes in studying innovative approaches for treating chronic neuropathic pain, with particular emphasis on exploring alternative therapeutic solutions.
- Neuropathic Pain Treatment
- Pain Management Innovation
- Chronic Pain Therapeutics
The research encompasses evaluating analgesic interventions and their effectiveness in managing chronic pain conditions.
Therapeutic Applications
The investigator focuses on examining the potential of cannabinoid-based treatments in medical applications, specifically their role in pain management.
- Cannabinoid Therapeutics
- Medical Cannabis Research
- Treatment Response Analysis
Their work includes studying therapeutic responses across different patient subgroups.
Clinical Assessment
Expertise in conducting detailed clinical assessments using Quantitative Sensory Testing (QST) to evaluate pain mechanisms and treatment responses.
- Pain Assessment Methods
- Patient Phenotyping
- Clinical Evaluation Techniques
The research involves analyzing phenotypical variations in pain response patterns.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.